Germany
Japan
United Kingdom
China
DVL3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
WNT Pathway Markers-Plasmids
View as table DownloadDVL2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
MAPK10 - Human, 4 unique 29mer shRNA constructs in retroviral RFP vector
| Format | Retroviral plasmids |
| Vector | pRFP-C-RS |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
WNT3 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
WNT6 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
LRP6 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
LRP5 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
MAPK10 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
TCF21 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
DVL2 - Human, 4 unique 29mer shRNA constructs in retroviral GFP vector
| Format | Retroviral plasmids |
| Vector | pGFP-V-RS |
| E. coli Selection | Kanamycin |
| Mammalian Cell Selection | Puromycin |
TCF21 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
Lenti-ORF clone of PTK7 (mGFP-tagged)-Human PTK7 protein tyrosine kinase 7 (PTK7), transcript variant PTK7-1
| Vector | pLenti-C-mGFP-P2A-Puro |
| Tag | mGFP |
| Mammalian Cell Selection | Puromycin |
- LentiORF®
PTK7 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
TCF7L2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
FZD8 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
WNT9A - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
WNT11 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
WNT1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
TCF4 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
ROCK1 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
FZD2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
APC2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
WNT7B - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
APOC2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
ROR2 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
MAPK10 - Human, 4 unique 29mer shRNA constructs in lentiviral GFP vector
| Format | Lentiviral plasmids |
| Vector | pGFP-C-shLenti |
| E. coli Selection | Chloramphenicol |
| Mammalian Cell Selection | Puromycin |
PTK7 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
WNT3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
WNT9A - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
WNT2B - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
WNT11 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
WNT1 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
TCF4 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
TCF21 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
DVL3 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
WNT7B - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
APOC2 - Human, 4 unique 29mer shRNA constructs in retroviral untagged vector
| Format | Retroviral plasmids |
| Vector | pRS |
| E. coli Selection | Ampicillin |
| Mammalian Cell Selection | Puromycin |
Active filters
Mammalian Cell Selection
- Puromycin
Filter by
Target Symbol
- TCF7L2 (38)
- MAPK9 (22)
- ANAPC11 (18)
- RORA (16)
- MAPK10 (14)
- PTK7 (14)
- TCF4 (13)
- FZD6 (12)
- MAPK8 (12)
- WNT7B (12)
- LEF1 (11)
- ANAPC5 (10)
- WNT9A (10)
- DVL3 (9)
- ROR1 (9)
- RYK (9)
- WNT3 (9)
- APOC2 (8)
- FZD2 (8)
- ROCK1 (8)
- ROR2 (8)
- TCF21 (8)
- TCF25 (8)
- WISP1 (8)
- WNT1 (8)
- WNT5B (8)
- WNT6 (8)
- DVL2 (7)
- LRP6 (7)
- WNT16 (7)
- ANAPC10 (6)
- ANAPC2 (6)
- DVL1 (6)
- FZD1 (6)
- FZD3 (6)
- FZD4 (6)
- FZD5 (6)
- JKAMP (6)
- SLC25A23 (6)
- WNT10A (6)
- WNT11 (6)
- WNT2B (6)
- WNT4 (6)
- FZD9 (5)
- LRP5 (5)
- WISP3 (5)
- WNT7A (5)
- ANAPC13 (4)
- ANAPC15 (4)
- ANAPC16 (4)
- FZD10 (4)
- LRP5L (4)
- WISP2 (4)
- WNT2 (4)
- FZD8 (3)
- WNT3A (3)
- WNT5A (3)
- 3200002M19RIK (2)
- APCS (2)
- CDK2AP1 (2)
- E2F1 (2)
- H2AFV (2)
- ROCK2 (2)
- APC2 (1)
Species
Lentivirus
Tags
Vectors
Mutants
Families
- Druggable Genome (151)
- Transmembrane (62)
- ES Cell Differentiation/IPS (47)
- Secreted Protein (39)
- Transcription Factors (38)
- Protein Kinase (37)
- Adult stem cells (21)
- GPCR (19)
- Stem cell relevant signaling - Wnt Signaling pathway (15)
- Cancer stem cells (11)
- Nuclear Hormone Receptor (8)
- Embryonic stem cells (4)
- Stem cell relevant signaling - DSL/Notch pathway (4)
- Induced pluripotent stem cells (2)
Pathways
- Wnt signaling pathway (106)
- Pathways in cancer (101)
- Basal cell carcinoma (82)
- Melanogenesis (82)
- Colorectal cancer (72)
- Progesterone-mediated oocyte maturation (43)
- Hedgehog signaling pathway (29)
- Acute myeloid leukemia (26)
- Adherens junction (26)
- Arrhythmogenic right ventricular cardiomyopathy (ARVC) (26)
- Endometrial cancer (26)
- Prostate cancer (26)
- Thyroid cancer (26)
- Cell cycle (24)
- Oocyte meiosis (24)
- Ubiquitin mediated proteolysis (24)
- Focal adhesion (21)
- Adipocytokine signaling pathway (19)
- Epithelial cell signaling in Helicobacter pylori infection (19)
- ErbB signaling pathway (19)
- Fc epsilon RI signaling pathway (19)
- GnRH signaling pathway (19)
- Insulin signaling pathway (19)
- MAPK signaling pathway (19)
- NOD-like receptor signaling pathway (19)
- Neurotrophin signaling pathway (19)
- Pancreatic cancer (19)
- RIG-I-like receptor signaling pathway (19)
- Toll-like receptor signaling pathway (19)
- Type II diabetes mellitus (19)
- T cell receptor signaling pathway (8)
- Notch signaling pathway (6)
- Axon guidance (2)
- Chemokine signaling pathway (2)
- Leukocyte transendothelial migration (2)
- Pathogenic Escherichia coli infection (2)
- Regulation of actin cytoskeleton (2)
- TGF-beta signaling pathway (2)
- Vascular smooth muscle contraction (2)